# First Time in Human Study With GSK1325756

> **NCT01209052** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 58 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK1325756
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01209052
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-15
- **Primary completion:** 2010-03-02
- **Final completion:** 2010-03-02
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01209052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01209052, "First Time in Human Study With GSK1325756". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01209052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*